Order Article Reprints

Ventura D, Schindler P, Masthoff M, Görlich D, Dittmann M, Heindel W, Schäfers M, Lenz G, Wardelmann E, Mohr M, et al. Radiomics of Tumor Heterogeneity in ¹⁸F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer. Cancers. 2023; 15(8):2297. https://doi.org/10.3390/cancers15082297

Ventura, David, Philipp Schindler, Max Masthoff, Dennis Görlich, Matthias Dittmann, Walter Heindel, Michael Schäfers, Georg Lenz, Eva Wardelmann, Michael Mohr, and et al. 2023. "Radiomics of Tumor Heterogeneity in ¹⁸F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer" Cancers 15, no. 8: 2297. https://doi.org/10.3390/cancers15082297

Ventura, D., Schindler, P., Masthoff, M., Görlich, D., Dittmann, M., Heindel, W., Schäfers, M., Lenz, G., Wardelmann, E., Mohr, M., Kies, P., Bleckmann, A., Roll, W., & Evers, G. (2023). Radiomics of Tumor Heterogeneity in ¹⁸F-FDG-PET-CT for Predicting Response to Immune Checkpoint Inhibition in Therapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer. Cancers, 15(8), 2297. https://doi.org/10.3390/cancers15082297